2019
DOI: 10.1111/trf.15398
|View full text |Cite
|
Sign up to set email alerts
|

Impact of cold storage on platelets treated with Intercept pathogen inactivation

Abstract: BACKGROUND: Pathogen inactivation and cold or cryopreservation of platelets (PLTs) both significantly affect PLT function. It is not known how PLTs function when both are combined. STUDY DESIGN AND METHODS: Standard PLTconcentrates (PCs) were compared to pathogeninactivated PCs treated with amotosalen photochemical treatment (AS-PCT) when stored at room (RT, 22 C), cold (4 C, n = 6), or cryopreservation (−80 C, n = 8) temperatures. The impact of alternative storage methods on both arms was studied in flow cyto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
28
2
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 28 publications
(32 citation statements)
references
References 56 publications
1
28
2
1
Order By: Relevance
“…In our study, Intercept treatment did not lead to an increase in P‐selectin expression compared to normal cold PLT storage. While previous groups have reported increased PLT PS expression and cell death due to Intercept treatment, 37,41 our work observed significantly increased PS expression (compared to same‐day control) in Amicus/plasma samples only at Day 21 of storage, whereas increased plasma membrane breakdown was observed at Day 14 and 21 of storage for Trima/plasma and Amicus/plasma samples, respectively. Instead, the increased PS expression was reflective of cold storage than Intercept treatment.…”
Section: Discussioncontrasting
confidence: 80%
See 1 more Smart Citation
“…In our study, Intercept treatment did not lead to an increase in P‐selectin expression compared to normal cold PLT storage. While previous groups have reported increased PLT PS expression and cell death due to Intercept treatment, 37,41 our work observed significantly increased PS expression (compared to same‐day control) in Amicus/plasma samples only at Day 21 of storage, whereas increased plasma membrane breakdown was observed at Day 14 and 21 of storage for Trima/plasma and Amicus/plasma samples, respectively. Instead, the increased PS expression was reflective of cold storage than Intercept treatment.…”
Section: Discussioncontrasting
confidence: 80%
“…While Intercept treatment did not dramatically alter ETP, it did result in shortened lag times and increased peak thrombin levels after 7 days of storage. A similar finding was observed in whole blood–derived PLT concentrates that were Intercept‐treated and cold stored for 5 days 37 …”
Section: Discussionsupporting
confidence: 80%
“…However, aggregation is detected with strong agonists like thrombin or collagen added at high concentrations [22]. Furthermore, when several agonists are combined like thrombin receptor agonist peptide 6 (TRAP-6) with ADP and epinephrine substantial aggregation is detected in cryopreserved platelets albeit two-to three-fold lower than in RT stored platelets [17,37]. Ristocetin induced agglutination requires less outside-in signaling to crosslink platelets via GPIbα and VWF compared to agonist induced aggregation which crosslinks platelets via fibrinogen and integrin α IIb β 3 .…”
Section: Agonist-induced Integrin Activation and Aggregationmentioning
confidence: 99%
“…Foremost, the platelet concentrate itself varies between studies because platelet separation methods are different throughout the globe. Resulting variables are platelet concentration, platelet additive solution, type of storage bag and pathogen inactivation [37].…”
Section: Efficacymentioning
confidence: 99%
See 1 more Smart Citation